163 related articles for article (PubMed ID: 33172404)
1. Association between apoptosis inhibitor of macrophage and microsatellite instability status in colorectal cancer.
Huang WJ; Wang X; Zhang ML; Li L; Wang RT
BMC Gastroenterol; 2020 Nov; 20(1):373. PubMed ID: 33172404
[TBL] [Abstract][Full Text] [Related]
2. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
[TBL] [Abstract][Full Text] [Related]
3. Subtyping of microsatellite instability-high colorectal cancer.
Hu W; Yang Y; Qi L; Chen J; Ge W; Zheng S
Cell Commun Signal; 2019 Jul; 17(1):79. PubMed ID: 31331345
[TBL] [Abstract][Full Text] [Related]
4. Combined Microsatellite Instability and Elevated Microsatellite Alterations at Selected Tetranucleotide Repeats (EMAST) Might Be a More Promising Immune Biomarker in Colorectal Cancer.
Chen MH; Chang SC; Lin PC; Yang SH; Lin CC; Lan YT; Lin HH; Lin CH; Lai JI; Liang WY; Lu ML; Yang MH; Chao Y
Oncologist; 2019 Dec; 24(12):1534-1542. PubMed ID: 31292272
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study.
Karaoglan BB; Akyol C; Unal AE; Kuzu A; Savaş B; Utkan G
J Gastrointest Cancer; 2024 Mar; 55(1):281-286. PubMed ID: 37414939
[TBL] [Abstract][Full Text] [Related]
6. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses.
Carr PR; Alwers E; Bienert S; Weberpals J; Kloor M; Brenner H; Hoffmeister M
Ann Oncol; 2018 Apr; 29(4):825-834. PubMed ID: 29438474
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome and Network Dissection of Microsatellite Stable and Highly Instable Colorectal Cancer.
Akbari V; Kallhor M; Mollashahi B; Movafagh A
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2445-2454. PubMed ID: 31450919
[TBL] [Abstract][Full Text] [Related]
8. Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Ooki A; Akagi K; Yatsuoka T; Asayama M; Hara H; Takahashi A; Kakuta M; Nishimura Y; Yamaguchi K
J Surg Oncol; 2014 Dec; 110(8):982-8. PubMed ID: 25154726
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer.
Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH
Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858
[TBL] [Abstract][Full Text] [Related]
10. Beneficial influence of microsatellite instability on gelatinase-tissue inhibitors of metalloproteinase balance in colorectal cancer.
Thiéfin G; Dupont A; Guillou PJ; Vitry F; Bouche O; Yaziji N; Lagarde S; Maquart FX; Palot JP; Hornebeck W; Diebold MD
Anticancer Res; 2007; 27(1B):583-8. PubMed ID: 17348445
[TBL] [Abstract][Full Text] [Related]
11. MSI status is associated with distinct clinicopathological features in BRAF mutation colorectal cancer: A systematic review and meta-analysis.
Wu M; Kim YS; Ryu HS; Choi SC; Kim KY; Park WC; Kim MS; Myung JY; Choi HS; Kim EJ; Lee MY
Pathol Res Pract; 2020 Jan; 216(1):152791. PubMed ID: 31866097
[TBL] [Abstract][Full Text] [Related]
12. Microsatellite instability status affects gene expression profiles in early onset colorectal cancer patients.
Ak S; Tunca B; Yilmazlar T; Tezcan G; Cecener G; Egeli U; Ozturk E; Yerci O; Ertürk E; Zorluoglu A
J Surg Res; 2013 Dec; 185(2):626-37. PubMed ID: 23992855
[TBL] [Abstract][Full Text] [Related]
13. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic characteristics of colorectal cancer with microsatellite instability.
Ziadi S; Ksiaa F; Ben Gacem R; Labaied N; Mokni M; Trimeche M
Pathol Res Pract; 2014 Feb; 210(2):98-104. PubMed ID: 24286815
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer.
Lin A; Zhang J; Luo P
Front Immunol; 2020; 11():2039. PubMed ID: 32903444
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
[TBL] [Abstract][Full Text] [Related]
17. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications.
Marginean EC; Melosky B
Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791
[TBL] [Abstract][Full Text] [Related]
18. Decreased mean platelet volume is associated with microsatellite instability in colorectal cancer: A propensity score-matched analysis.
Wang W; Wang G; Fu S; Zhang B; Liu Z; Wang R
Cancer Biomark; 2021; 31(4):351-359. PubMed ID: 33896834
[TBL] [Abstract][Full Text] [Related]
19. The value of single-source dual-energy CT imaging for discriminating microsatellite instability from microsatellite stability human colorectal cancer.
Wu J; Lv Y; Wang N; Zhao Y; Zhang P; Liu Y; Chen A; Li J; Li X; Guo Y; Wu T; Liu A
Eur Radiol; 2019 Jul; 29(7):3782-3790. PubMed ID: 30903331
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy.
Bao X; Zhang H; Wu W; Cheng S; Dai X; Zhu X; Fu Q; Tong Z; Liu L; Zheng Y; Zhao P; Fang W; Liu F
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33028695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
